Adamis Pharmaceuticals Corp - FORM 10-K - EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - July 6, 2011

Attached files

file filename
10-K - ANNUAL REPORT - Adamis Pharmaceuticals Corpadamis-10k_0627.htm
EX-10.46 - LICENSE AGREEMENT DATED JANUARY 2, 2008, WITH WISCONSIN ALUMNI RESEARCH FOUNDATION - Adamis Pharmaceuticals Corpex-10_46.htm
EX-10.45 - LICENSE AGREEMENT DATED JANUARY 26, 2007, WITH WISCONSIN ALUMNI RESEARCH FOUNDATION - Adamis Pharmaceuticals Corpex-10_45.htm
EX-10.47 - FIRST AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT - Adamis Pharmaceuticals Corpex-10_47.htm
EX-10.44 - LICENSE AGREEMENT DATED JANUARY 26, 2007, WITH WISCONSIN ALUMNI RESEARCH FOUNDATION - Adamis Pharmaceuticals Corpex-10_44.htm
EX-10.43 - LICENSE AGREEMENT BETWEEN ADAMIS, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AND DANA-FARBER CANCER INSTITUTE, INC. - Adamis Pharmaceuticals Corpex-10_43.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex-31_1.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex-32_1.htm
EX-21.1 - SUBSIDIARIES LIST - Adamis Pharmaceuticals Corpex-21_1.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Adamis Pharmaceuticals Corpex-23_1.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex-31_2.htm
EXHIBIT 32.2
 
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
 
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
 
The undersigned, Robert O. Hopkins, as Vice President, Finance and Chief Financial Officer of Adamis Pharmaceuticals, Corporation (the “Company”), pursuant to 18 U.S.C.  1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge:
 
 
 (1) the Company’s Annual Report on Form 10-K for the year ended March 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
   
 
 (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

   
 
/s/ ROBERT O. HOPKINS
 
Robert O. Hopkins
 
Vice President and Chief Financial Officer
 
Dated: July 6, 2011 
 
 
This certification is being furnished to the SEC with this Report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.

Stock widget

Investing forum

Adamis Pharmaceuticals Corp Reports

Also read